Guggenheim Lifts PT on AstraZeneca PLC (AZN) to 16,500 GBp From 16,000 GBp

AstraZeneca PLC (NYSE:AZN) is one of the best pharma stocks to invest in now. AstraZeneca PLC (NYSE:AZN) received a rating update from Guggenheim on March 30. The firm lifted the price target on the stock to 16,500 GBp from 16,000 GBp, reiterating a Buy rating on the shares. The rating update came as the firm updated its model ahead of the company’s fiscal Q1 earnings.

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built on Innovation

In another development, AstraZeneca PLC (NYSE:AZN) reported on March 27 positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease. The company stated that tozorakimab reduced the annualised rate of moderate-to-severe COPD exacerbations compared with placebo, in the primary population of former smokers, and in the overall population. The overall population included former and current smokers, as well as patients across all blood eosinophil counts and all stages of lung function severity. Management added that Tozorakimab is a potential first-in-class monoclonal antibody targeting interleukin-33, and was generally well tolerated with a favourable safety profile.

AstraZeneca PLC (NYSE:AZN) is a biopharmaceutical company that explores, develops, manufactures, and commercializes prescription medicines. It supplies its products and services to specialty and primary care physicians, and is involved in exploring novel immuno-oncology treatment approaches. AstraZeneca PLC (NYSE:AZN) distributes its products and services through local representative offices and distributors.

While we acknowledge the risk and potential of AZN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AZN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Follow Insider Monkey on Google News.